Objective: To determine the serum levels and frequency of antiphospholipid antibodies (aPLs) and confirm the clinical importance of this antibodies in patients with autoimmune blistering disease (ABD).
INTRODUCTION
Autoimmune blistering disease (ABD) is a typical acquired organ-specific autoimmune disease forming blisters on the skin and/or mucous membranes 1 . Pemphigus, including pemphigus vulgaris (PV) and pemphigus foliaceous (PF), is an autoimmune intraepidermal blistering diseases that target desmoglein 2 . Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease that target BP180/NC16a 3 .
The antiphospholipid syndrome (APS) is an acquired multisystem disorder characterized by hypercoagulation in which thrombosis and recurrent fetal loss develop 4 . The serological markers for this syndrome are antiphospholipid antibodies (aPLs), such as the lupus anticoagulant (LA), anti-cardiolipin antibody (aCL) 5, 6 , antibody against anticardiolipin β 2 -glycoprotein I complex antibody (CL/β 2 GPI), and anti-phosphatidylserine-prothrombin complex antibody (aPS/PT) 7, 8 . aPLs are frequently found in patients with systemic autoimmune diseases, especially in systemic lupus erythematosus (SLE). They are also found in patients with organ-specific autoimmune diseases [9] [10] [11] [12] [13] [14] [15] [16] , however the frequency of aPL in ABD remains unknown. In this study, we investigated whether aPLs were detected in patients with ABD, and whether these Abs correlated with the clinical symptoms of APS. 
METHODS

Patients and serum samples
Detection of aPLs
The 
Statistical analysis
Statistical analysis was performed using Fisher's exact probability test for the comparison of frequencies. A p value less than 0.05 was considered statistically significant.
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RESULTS
Prevalence of aPLs in patients with ABD, SLE, and normal controls
Values higher than the mean + 2SD of the normal control serum samples were considered positive in this study. IgG aCL was detected more frequently in the patients with ABD (22.4%), PV (23.8%), PF (25.0%), BP (19.2%), and SLE (31.0%) than in the normal controls (0%, p<0.01, respectively, Figure 1A) . The detection rate of IgM aCL was higher in the patients with PV (15.0%, p<0.05) and SLE (20.7%, p<0.01) than in normal controls (0%, Figure 1B ). IgG aCL/β 2 GPI was detected more frequently in the patients with BP (14.3%, p<0.05) and SLE (27.6%, p<0.01) than in the normal controls (0%, Figure 1C Figure 1D ).
Association of aPL with clinical features
LA, IgG aCL, IgM aCL, aCL/β 2 GPI, and aPS/PT were detected in 6/20 (30%), 7/20 (35%), 3/14 (21%), 0/20 (0%), and 3/17 (18%) patients with ABD attending our hospital in 2004, respectively ( Table I) . Ten of 20 (50%) patients with ABD were positive for any one of aPLs, and five of ten patients had plural aPLs. Thromboembolism was detected in 7/10 (70%) patients with aPLs, while a history of intrauterine fetal loss was not found in any of the patients.
Interestingly, all patients with plural aPLs had clinical signs of thromboembolism.
COMMENT
In the present study, IgG aCL, IgM aCL, IgG aCL/β 2 GPI, and IgG aPS/PT were positive for 22.4%, 9.1%, 9.9%, and 25.4% of ABD patients, respectively (Figure 1) .
Thromboembolism was detected in high frequency (7/10 cases, 70%) in ABD patients with aPLs ( Table I) .
It is well known that aPLs are frequently detected in SLE and some systemic autoimmune diseases, and SLE comprised 36% of the cases among those with secondary APS 20 . However, recent studies indicate that aPLs have also been detected in organ-specific autoimmune diseases, such as insulin dependent diabetes mellitus (34%) 9, 10 , myasthenia gravis (22%) 11 , autoimmune thyroid diseases (43~55%) 12, 13 , inflammatory bowel disease (16~18%) 14, 15 , and localized scleroderma (46%) 16 . Nevertheless, aPL positive patients with these diseases infrequently show clinical signs of thromboembolism 9, [11] [12] [13] [14] [15] [16] . Only in patients with insulin dependent diabetes mellitus, the presence of aPLs is associated with complications throughout the pregnancy 10 . Our findings suggest that ABD is another organ-specific autoimmune disease that can be accompanied by APS.
Since most of thromboembolism was asymptomatic in ABD patients (Table I) ,
hypercoagulative states due to aPLs may be modest in ABD patients compared with patients with primary APS or SLE. Nonetheless, we propose that patients with ABD should be examined for the presence of aPLs, since the frequency of some aPLs was significantly higher than that in normal controls. While systemic corticosteroid is often used for treatment of ABD, this may enhance the hypercoagulative states. Therefore, careful observation and follow up may be required to prevent symptomatic thrombotic events in patients with aPLs. Further follow-up studies, especially with a large patient group, will be needed to clarify the clinical relevance of aPLs in ABD. 
